Apellis Pharmaceuticals buy RudolfL
Start price
03.04.22
/
50%
€52.04
Target price
03.04.23
€69.00
Performance (%)
31.30%
End price
24.08.22
€68.33
Summary
This prediction ended on 24.08.22 with a price of €68.33. The BUY prediction by RudolfL for Apellis Pharmaceuticals saw massive gains of 31.30%. RudolfL has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Apellis Pharmaceuticals | - | - | - | - |
| iShares Core DAX® | -1.212% | 1.925% | 17.589% | 68.786% |
| iShares Nasdaq 100 | -4.714% | -1.810% | 0.450% | 100.066% |
| iShares Nikkei 225® | -2.976% | -2.660% | 10.156% | 43.024% |
| iShares S&P 500 | -2.744% | -0.448% | 0.320% | 63.222% |
Comments by RudolfL for this prediction
In the thread Apellis Pharmaceuticals diskutieren
Buy mit Kursziel 55,0
Kursziel geändert auf 69,0
In the thread Trading Apellis Pharmaceuticals
Buy beendet
Stopped prediction by RudolfL for Apellis Pharmaceuticals
Apellis Pharmaceuticals
Start price
Target price
Perf. (%)
€25.01
13.10.24
13.10.24
-
13.10.25
13.10.25
10.38%
10.01.25
10.01.25

